 | • レポートコード：MRC2312MG01097 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、72ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のクリスタロイド点滴液市場規模と予測を収録しています。・世界のクリスタロイド点滴液市場：売上、2018年-2023年、2024年-2029年 ・世界のクリスタロイド点滴液市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のクリスタロイド点滴液市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「等張晶質溶液」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 クリスタロイド点滴液のグローバル主要企業は、Baxter、 Kelun Group、 Fresenius Kabi、 Otsuka、 ICU Medical、 B. Braun Melsungen、 JW Life Scienceなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、クリスタロイド点滴液のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のクリスタロイド点滴液市場：タイプ別、2018年-2023年、2024年-2029年 世界のクリスタロイド点滴液市場：タイプ別市場シェア、2022年 ・等張晶質溶液、高張晶質溶液、低張晶質溶液 世界のクリスタロイド点滴液市場：用途別、2018年-2023年、2024年-2029年 世界のクリスタロイド点滴液市場：用途別市場シェア、2022年 ・基礎輸液、栄養輸液、その他 世界のクリスタロイド点滴液市場：地域・国別、2018年-2023年、2024年-2029年 世界のクリスタロイド点滴液市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるクリスタロイド点滴液のグローバル売上、2018年-2023年 ・主要企業におけるクリスタロイド点滴液のグローバル売上シェア、2022年 ・主要企業におけるクリスタロイド点滴液のグローバル販売量、2018年-2023年 ・主要企業におけるクリスタロイド点滴液のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Baxter、 Kelun Group、 Fresenius Kabi、 Otsuka、 ICU Medical、 B. Braun Melsungen、 JW Life Science ************************************************************* ・調査・分析レポートの概要 クリスタロイド点滴液市場の定義 市場セグメント 世界のクリスタロイド点滴液市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のクリスタロイド点滴液市場規模 世界のクリスタロイド点滴液市場規模：2022年 VS 2029年 世界のクリスタロイド点滴液市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのクリスタロイド点滴液の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のクリスタロイド点滴液製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：等張晶質溶液、高張晶質溶液、低張晶質溶液 クリスタロイド点滴液のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：基礎輸液、栄養輸液、その他 クリスタロイド点滴液の用途別グローバル売上・予測 ・地域別市場分析 地域別クリスタロイド点滴液市場規模 2022年と2029年 地域別クリスタロイド点滴液売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Baxter、 Kelun Group、 Fresenius Kabi、 Otsuka、 ICU Medical、 B. Braun Melsungen、 JW Life Science ... |
This research report provides a comprehensive analysis of the Crystalloid Intravenous Fluids market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Crystalloid Intravenous Fluids market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Crystalloid Intravenous Fluids, challenges faced by the industry, and potential opportunities for market players.
The global Crystalloid Intravenous Fluids market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Crystalloid Intravenous Fluids market presents opportunities for various stakeholders, including Basic IV Solutions, Nutrient Infusion Solution. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Crystalloid Intravenous Fluids market. Additionally, the growing consumer demand present avenues for market expansion.
The global Crystalloid Intravenous Fluids market was valued at US$ 8710.3 million in 2022 and is projected to reach US$ 13530 million by 2029, at a CAGR of 6.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Crystalloid Intravenous Fluids market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Crystalloid Intravenous Fluids market.
Market Overview: The report provides a comprehensive overview of the Crystalloid Intravenous Fluids market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Isotonic Crystalloid Solutions, Hypertonic Crystalloid Solutions), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Crystalloid Intravenous Fluids market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Crystalloid Intravenous Fluids market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Crystalloid Intravenous Fluids market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Crystalloid Intravenous Fluids market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Crystalloid Intravenous Fluids market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Crystalloid Intravenous Fluids market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Crystalloid Intravenous Fluids, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Crystalloid Intravenous Fluids market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Crystalloid Intravenous Fluids market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Isotonic Crystalloid Solutions
Hypertonic Crystalloid Solutions
Hypotonic Crystalloid Solutions
Market segment by Application
Basic IV Solutions
Nutrient Infusion Solution
Others
Global Crystalloid Intravenous Fluids Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Baxter
Kelun Group
Fresenius Kabi
Otsuka
ICU Medical
B. Braun Melsungen
JW Life Science
Outline of Major Chapters:
Chapter 1: Introduces the definition of Crystalloid Intravenous Fluids, market overview.
Chapter 2: Global Crystalloid Intravenous Fluids market size in revenue and volume.
Chapter 3: Detailed analysis of Crystalloid Intravenous Fluids manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Crystalloid Intravenous Fluids in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Crystalloid Intravenous Fluids capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Crystalloid Intravenous Fluids Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Crystalloid Intravenous Fluids Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Crystalloid Intravenous Fluids Overall Market Size
2.1 Global Crystalloid Intravenous Fluids Market Size: 2022 VS 2029
2.2 Global Crystalloid Intravenous Fluids Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Crystalloid Intravenous Fluids Sales: 2018-2029
3 Company Landscape
3.1 Top Crystalloid Intravenous Fluids Players in Global Market
3.2 Top Global Crystalloid Intravenous Fluids Companies Ranked by Revenue
3.3 Global Crystalloid Intravenous Fluids Revenue by Companies
3.4 Global Crystalloid Intravenous Fluids Sales by Companies
3.5 Global Crystalloid Intravenous Fluids Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Crystalloid Intravenous Fluids Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Crystalloid Intravenous Fluids Product Type
3.8 Tier 1, Tier 2 and Tier 3 Crystalloid Intravenous Fluids Players in Global Market
3.8.1 List of Global Tier 1 Crystalloid Intravenous Fluids Companies
3.8.2 List of Global Tier 2 and Tier 3 Crystalloid Intravenous Fluids Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Crystalloid Intravenous Fluids Market Size Markets, 2022 & 2029
4.1.2 Isotonic Crystalloid Solutions
4.1.3 Hypertonic Crystalloid Solutions
4.1.4 Hypotonic Crystalloid Solutions
4.2 By Type – Global Crystalloid Intravenous Fluids Revenue & Forecasts
4.2.1 By Type – Global Crystalloid Intravenous Fluids Revenue, 2018-2023
4.2.2 By Type – Global Crystalloid Intravenous Fluids Revenue, 2024-2029
4.2.3 By Type – Global Crystalloid Intravenous Fluids Revenue Market Share, 2018-2029
4.3 By Type – Global Crystalloid Intravenous Fluids Sales & Forecasts
4.3.1 By Type – Global Crystalloid Intravenous Fluids Sales, 2018-2023
4.3.2 By Type – Global Crystalloid Intravenous Fluids Sales, 2024-2029
4.3.3 By Type – Global Crystalloid Intravenous Fluids Sales Market Share, 2018-2029
4.4 By Type – Global Crystalloid Intravenous Fluids Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Crystalloid Intravenous Fluids Market Size, 2022 & 2029
5.1.2 Basic IV Solutions
5.1.3 Nutrient Infusion Solution
5.1.4 Others
5.2 By Application – Global Crystalloid Intravenous Fluids Revenue & Forecasts
5.2.1 By Application – Global Crystalloid Intravenous Fluids Revenue, 2018-2023
5.2.2 By Application – Global Crystalloid Intravenous Fluids Revenue, 2024-2029
5.2.3 By Application – Global Crystalloid Intravenous Fluids Revenue Market Share, 2018-2029
5.3 By Application – Global Crystalloid Intravenous Fluids Sales & Forecasts
5.3.1 By Application – Global Crystalloid Intravenous Fluids Sales, 2018-2023
5.3.2 By Application – Global Crystalloid Intravenous Fluids Sales, 2024-2029
5.3.3 By Application – Global Crystalloid Intravenous Fluids Sales Market Share, 2018-2029
5.4 By Application – Global Crystalloid Intravenous Fluids Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Crystalloid Intravenous Fluids Market Size, 2022 & 2029
6.2 By Region – Global Crystalloid Intravenous Fluids Revenue & Forecasts
6.2.1 By Region – Global Crystalloid Intravenous Fluids Revenue, 2018-2023
6.2.2 By Region – Global Crystalloid Intravenous Fluids Revenue, 2024-2029
6.2.3 By Region – Global Crystalloid Intravenous Fluids Revenue Market Share, 2018-2029
6.3 By Region – Global Crystalloid Intravenous Fluids Sales & Forecasts
6.3.1 By Region – Global Crystalloid Intravenous Fluids Sales, 2018-2023
6.3.2 By Region – Global Crystalloid Intravenous Fluids Sales, 2024-2029
6.3.3 By Region – Global Crystalloid Intravenous Fluids Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Crystalloid Intravenous Fluids Revenue, 2018-2029
6.4.2 By Country – North America Crystalloid Intravenous Fluids Sales, 2018-2029
6.4.3 US Crystalloid Intravenous Fluids Market Size, 2018-2029
6.4.4 Canada Crystalloid Intravenous Fluids Market Size, 2018-2029
6.4.5 Mexico Crystalloid Intravenous Fluids Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Crystalloid Intravenous Fluids Revenue, 2018-2029
6.5.2 By Country – Europe Crystalloid Intravenous Fluids Sales, 2018-2029
6.5.3 Germany Crystalloid Intravenous Fluids Market Size, 2018-2029
6.5.4 France Crystalloid Intravenous Fluids Market Size, 2018-2029
6.5.5 U.K. Crystalloid Intravenous Fluids Market Size, 2018-2029
6.5.6 Italy Crystalloid Intravenous Fluids Market Size, 2018-2029
6.5.7 Russia Crystalloid Intravenous Fluids Market Size, 2018-2029
6.5.8 Nordic Countries Crystalloid Intravenous Fluids Market Size, 2018-2029
6.5.9 Benelux Crystalloid Intravenous Fluids Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Crystalloid Intravenous Fluids Revenue, 2018-2029
6.6.2 By Region – Asia Crystalloid Intravenous Fluids Sales, 2018-2029
6.6.3 China Crystalloid Intravenous Fluids Market Size, 2018-2029
6.6.4 Japan Crystalloid Intravenous Fluids Market Size, 2018-2029
6.6.5 South Korea Crystalloid Intravenous Fluids Market Size, 2018-2029
6.6.6 Southeast Asia Crystalloid Intravenous Fluids Market Size, 2018-2029
6.6.7 India Crystalloid Intravenous Fluids Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Crystalloid Intravenous Fluids Revenue, 2018-2029
6.7.2 By Country – South America Crystalloid Intravenous Fluids Sales, 2018-2029
6.7.3 Brazil Crystalloid Intravenous Fluids Market Size, 2018-2029
6.7.4 Argentina Crystalloid Intravenous Fluids Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Crystalloid Intravenous Fluids Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Crystalloid Intravenous Fluids Sales, 2018-2029
6.8.3 Turkey Crystalloid Intravenous Fluids Market Size, 2018-2029
6.8.4 Israel Crystalloid Intravenous Fluids Market Size, 2018-2029
6.8.5 Saudi Arabia Crystalloid Intravenous Fluids Market Size, 2018-2029
6.8.6 UAE Crystalloid Intravenous Fluids Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Baxter
7.1.1 Baxter Company Summary
7.1.2 Baxter Business Overview
7.1.3 Baxter Crystalloid Intravenous Fluids Major Product Offerings
7.1.4 Baxter Crystalloid Intravenous Fluids Sales and Revenue in Global (2018-2023)
7.1.5 Baxter Key News & Latest Developments
7.2 Kelun Group
7.2.1 Kelun Group Company Summary
7.2.2 Kelun Group Business Overview
7.2.3 Kelun Group Crystalloid Intravenous Fluids Major Product Offerings
7.2.4 Kelun Group Crystalloid Intravenous Fluids Sales and Revenue in Global (2018-2023)
7.2.5 Kelun Group Key News & Latest Developments
7.3 Fresenius Kabi
7.3.1 Fresenius Kabi Company Summary
7.3.2 Fresenius Kabi Business Overview
7.3.3 Fresenius Kabi Crystalloid Intravenous Fluids Major Product Offerings
7.3.4 Fresenius Kabi Crystalloid Intravenous Fluids Sales and Revenue in Global (2018-2023)
7.3.5 Fresenius Kabi Key News & Latest Developments
7.4 Otsuka
7.4.1 Otsuka Company Summary
7.4.2 Otsuka Business Overview
7.4.3 Otsuka Crystalloid Intravenous Fluids Major Product Offerings
7.4.4 Otsuka Crystalloid Intravenous Fluids Sales and Revenue in Global (2018-2023)
7.4.5 Otsuka Key News & Latest Developments
7.5 ICU Medical
7.5.1 ICU Medical Company Summary
7.5.2 ICU Medical Business Overview
7.5.3 ICU Medical Crystalloid Intravenous Fluids Major Product Offerings
7.5.4 ICU Medical Crystalloid Intravenous Fluids Sales and Revenue in Global (2018-2023)
7.5.5 ICU Medical Key News & Latest Developments
7.6 B. Braun Melsungen
7.6.1 B. Braun Melsungen Company Summary
7.6.2 B. Braun Melsungen Business Overview
7.6.3 B. Braun Melsungen Crystalloid Intravenous Fluids Major Product Offerings
7.6.4 B. Braun Melsungen Crystalloid Intravenous Fluids Sales and Revenue in Global (2018-2023)
7.6.5 B. Braun Melsungen Key News & Latest Developments
7.7 JW Life Science
7.7.1 JW Life Science Company Summary
7.7.2 JW Life Science Business Overview
7.7.3 JW Life Science Crystalloid Intravenous Fluids Major Product Offerings
7.7.4 JW Life Science Crystalloid Intravenous Fluids Sales and Revenue in Global (2018-2023)
7.7.5 JW Life Science Key News & Latest Developments
8 Global Crystalloid Intravenous Fluids Production Capacity, Analysis
8.1 Global Crystalloid Intravenous Fluids Production Capacity, 2018-2029
8.2 Crystalloid Intravenous Fluids Production Capacity of Key Manufacturers in Global Market
8.3 Global Crystalloid Intravenous Fluids Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Crystalloid Intravenous Fluids Supply Chain Analysis
10.1 Crystalloid Intravenous Fluids Industry Value Chain
10.2 Crystalloid Intravenous Fluids Upstream Market
10.3 Crystalloid Intravenous Fluids Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Crystalloid Intravenous Fluids Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer